Spinout Active LTD

Company profile

Surepulse Medical Limited

UK company 08112962, incorporated on 20 June 2012.

SurePulse Medical - wireless monitoring for newborns

SurePulse VS provides wireless monitoring for newborns giving accurate, reliable, and timely information when every second counts.

Company number
08112962
Incorporated
20 Jun 2012
Companies House status
Active

Company identity

Browse spinouts
Founded / incorporated
20 June 2012

Company number 08112962

Verify at Companies House
Legal name
SUREPULSE MEDICAL LIMITED
Company type
LTD
Region
East Midlands
Registered address
Unknown
Insolvency history
No

Latest accounts

Financial period: 1 Jul 2023 to 30 Jun 2024

ABRIDGEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
9

Company events

Reference milestones and recent Companies House filing stream events.

4 events
22 Sep
2026

Capital Allotment Shares

Capital

SH01 | Transaction MzU0NjI4NDcyNGFkaXF6a2N4

Published 22 Sep 2026 14:50

08 Jul
2026

Resolution

Resolution

RESOLUTIONS | Transaction WUY1Qlg5ODlhZGlxemtjeA | Paper/PDF filed

Published 10 Jul 2026 00:55

07 Jul
2026

Capital Allotment Shares

Capital

SH01 | Transaction MzUzMTA0MTE0M2FkaXF6a2N4

Published 07 Jul 2026 19:57

20 Jun
2012

Incorporated

Inception

Company registered at Companies House

Spinout profile

1 entry

Company description

Medical devices design and manufacture

Project impact

Undertaking clinical trials at NUH

HeartLight Systems Ltd
2014

Public funding

4 awards
First funded
2015
Funded years
2015, 2018, 2019, 2023
Age at first award
2 years

Projects

2023 Collaborative R&D Lead participant

SurePulse: Next Generation Multiparameter Vital Signs Monitoring for Newborns

1 Jan 2023 to 31 Dec 2024

Awarded
£432,632
Total cost £618,046

One in ten babies need assistance with their breathing at birth i.e. 77,000/year (UK), 14 million/year worldwide. The reasons for this include being born too early or with unexpected birthing problems. Babies receiving optimal treatment quickly and efficiently will generally go on to lead normal lives, however, those where this is not the case are at risk...

2019 Feasibility Studies Lead participant

Surepulse - Monitoring The Newborn

1 Jan 2019 to 31 Dec 2019

Awarded
£138,436
Total cost £197,766

"Amazingly, 10% of babies need assistance with their breathing at birth ~14M/year worldwide. Reasons for this include being born too early or partial umbilical cord strangulation. Those who receive the necessary aid quickly/efficiently will generally go on to lead normal lives, however those for which this is not the case are at risk of harm including dam...

2018 Collaborative R&D Lead participant

Surepulse - a new way to monitor the heart rate of Newborns

1 Jun 2018 to 28 Feb 2019

Awarded
£24,803
Total cost £49,606

"Around 10% of babies need assistance with their breathing at birth -- equivalent to 14M every year globally. Reasons for this include being born too early or something untoward happening during birth such as strangulation by the umbilical cord. Those who receive the necessary aid quickly and efficiently will generally go on to lead normal lives, however ...

2015 Collaborative R&D Lead participant

HeartLight: Heart-Rate Monitoring for Neonatal Resuscitation

1 Mar 2015 to 28 Feb 2018

Awarded
£243,471
Total cost £405,785

Approximately 10% of newborns require some form of resuscitation at birth, for example because the baby doesn’t begin breathing after delivery. If babies are not resuscitated effectively they can suffer a range of poor outcomes, for example cerebral palsy due to low oxygen levels. Effective resuscitation is guided by changes in heart rate (HR). Current me...

Product types

Collaborative R&D Feasibility Studies